BioCentury | May 6, 2013
Company News

Algeta, Lumiphore deal

...Algeta exercised its option under an extended 2010 deal for an exclusive worldwide license to Lumiphore's...
...in the lanthanide and actinide groups to tumor-targeting molecules. Algeta also received a license from Lumiphore...
...of chelators, with the option of including a further selection of compounds within the license. Lumiphore...
BioCentury | Nov 1, 2010
Company News

Algeta, Lumiphore deal

...Algeta received an exclusive option for exclusive rights to use Lumiphore's Lumi4 isophthalamide chelation technology to...
...based on chelators that bind metals in the lanthanide and actinide groups to tumor-targeting molecules. Lumiphore...
...expire in one year. Further financial terms were not disclosed. Algeta ASA (OSE:ALGETA), Oslo, Norway Lumiphore Inc....
BioCentury | Jun 29, 2009
Company News

Brahms AG, Lumiphore deal

...Brahms received exclusive rights outside the U.S. to incorporate Lumiphore's Lumi4 fluorescent lanthanide detection reagents technology...
...including tests for Down syndrome. Financial terms were not disclosed. Brahms AG , Hennigsdorf, Germany Lumiphore Inc....
BioCentury | Sep 10, 2007
Company News

Cisbio, Lumiphore deal

...Cisbio received an exclusive, worldwide license to incorporate Lumiphore's Lumi4 fluorescent lanthanide detection reagents into Cisbio's...
...molecular interactions of proteins in vivo. Financial terms were not disclosed. Cisbio , Saclay, France Lumiphore Inc....
BioCentury | Nov 4, 2002
Company News

Lumiphore, University of California deal

...license from the university to two patents covering fluorescence detection technology using luminescent lanthanide complexes. Lumiphore Inc....
Items per page:
1 - 5 of 5
BioCentury | May 6, 2013
Company News

Algeta, Lumiphore deal

...Algeta exercised its option under an extended 2010 deal for an exclusive worldwide license to Lumiphore's...
...in the lanthanide and actinide groups to tumor-targeting molecules. Algeta also received a license from Lumiphore...
...of chelators, with the option of including a further selection of compounds within the license. Lumiphore...
BioCentury | Nov 1, 2010
Company News

Algeta, Lumiphore deal

...Algeta received an exclusive option for exclusive rights to use Lumiphore's Lumi4 isophthalamide chelation technology to...
...based on chelators that bind metals in the lanthanide and actinide groups to tumor-targeting molecules. Lumiphore...
...expire in one year. Further financial terms were not disclosed. Algeta ASA (OSE:ALGETA), Oslo, Norway Lumiphore Inc....
BioCentury | Jun 29, 2009
Company News

Brahms AG, Lumiphore deal

...Brahms received exclusive rights outside the U.S. to incorporate Lumiphore's Lumi4 fluorescent lanthanide detection reagents technology...
...including tests for Down syndrome. Financial terms were not disclosed. Brahms AG , Hennigsdorf, Germany Lumiphore Inc....
BioCentury | Sep 10, 2007
Company News

Cisbio, Lumiphore deal

...Cisbio received an exclusive, worldwide license to incorporate Lumiphore's Lumi4 fluorescent lanthanide detection reagents into Cisbio's...
...molecular interactions of proteins in vivo. Financial terms were not disclosed. Cisbio , Saclay, France Lumiphore Inc....
BioCentury | Nov 4, 2002
Company News

Lumiphore, University of California deal

...license from the university to two patents covering fluorescence detection technology using luminescent lanthanide complexes. Lumiphore Inc....
Items per page:
1 - 5 of 5